This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ramaswamy, S. Articles by Golub, T. R. Search for Related Content PubMed PubMed Citation Articles by Ramaswamy, S. Articles by Golub, T. R. Social Bookmarking                            What's this?

DNA Microarrays in Clinical Oncology

From the Departments of Adult Oncology and Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston; and Whitehead Institute/MIT Center for Genome Research, Cambridge, MA.

Address reprint requests to Todd R. Golub, MD, Dana-Farber Cancer Institute, 44 Binney St, D640, Boston, MA 02115; email: golub{at}genome.wi.mit.edu

ABSTRACT: Aberrant gene expression is critical for tumor initiation and progression. However, we lack a comprehensive understanding of all genes that are aberrantly expressed in human cancer. Recently, DNA microarrays have been used to obtain global views of human cancer gene expression and to identify genetic markers that might be important for diagnosis and therapy. We review clinical applications of these novel tools, discuss some important recent studies, identify promising avenues of research in this emerging field of study, and discuss the likely impact that expression profiling will have on clinical oncology.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. B. Overdevest, D. Theodorescu, and J. K. Lee Utilizing the Molecular Gateway: The Path to Personalized Cancer Management Clin. Chem., April 1, 2009; 55(4): 684 - 697. [Abstract] [Full Text] [PDF]

				S. J. Furney, B. Calvo, P. Larranaga, J. A. Lozano, and N. Lopez-Bigas Prioritization of candidate cancer genes--an aid to oncogenomic studies Nucleic Acids Res., October 1, 2008; 36(18): e115 - e115. [Abstract] [Full Text] [PDF]

				M. K. Kim, K.-J. Cho, G. Y. Kwon, S.-I. Park, Y. H. Kim, J. H. Kim, H.-Y. Song, J. H. Shin, H. Y. Jung, G. H. Lee, et al. Patients with ERCC1-Negative Locally Advanced Esophageal Cancers May Benefit from Preoperative Chemoradiotherapy Clin. Cancer Res., July 1, 2008; 14(13): 4225 - 4231. [Abstract] [Full Text] [PDF]

				B. S. Wittner, D. C. Sgroi, P. D. Ryan, T. J. Bruinsma, A. M. Glas, A. Male, S. Dahiya, K. Habin, R. Bernards, D. A. Haber, et al. Analysis of the MammaPrint Breast Cancer Assay in a Predominantly Postmenopausal Cohort Clin. Cancer Res., May 15, 2008; 14(10): 2988 - 2993. [Abstract] [Full Text] [PDF]

				C. I. Dumur, M. Lyons-Weiler, C. Sciulli, C. T. Garrett, I. Schrijver, T. K. Holley, J. Rodriguez-Paris, J. R. Pollack, J. L. Zehnder, M. Price, et al. Interlaboratory Performance of a Microarray-Based Gene Expression Test to Determine Tissue of Origin in Poorly Differentiated and Undifferentiated Cancers J. Mol. Diagn., January 1, 2008; 10(1): 67 - 77. [Abstract] [Full Text] [PDF]

				J. H. Cho-Vega, S. Tsavachidis, K.-A. Do, J. Nakagawa, L. J. Medeiros, and T. J. McDonnell Dicarbonyl/L-Xylulose Reductase: A Potential Biomarker Identified by Laser-Capture Microdissection-Micro Serial Analysis of Gene Expression of Human Prostate Adenocarcinoma Cancer Epidemiol. Biomarkers Prev., December 1, 2007; 16(12): 2615 - 2622. [Abstract] [Full Text] [PDF]

				E. T. Olejniczak, C. Van Sant, M. G. Anderson, G. Wang, S. K. Tahir, G. Sauter, R. Lesniewski, and D. Semizarov Integrative Genomic Analysis of Small-Cell Lung Carcinoma Reveals Correlates of Sensitivity to Bcl-2 Antagonists and Uncovers Novel Chromosomal Gains Mol. Cancer Res., April 1, 2007; 5(4): 331 - 339. [Abstract] [Full Text] [PDF]

				R. Mehrian-Shai, C. D. Chen, T. Shi, S. Horvath, S. F. Nelson, J. K. V. Reichardt, and C. L. Sawyers Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K/Akt pathway activation in glioblastoma and prostate cancer PNAS, March 27, 2007; 104(13): 5563 - 5568. [Abstract] [Full Text] [PDF]

				J. Jaeger, D. Koczan, H.-J. Thiesen, S. M. Ibrahim, G. Gross, R. Spang, and M. Kunz Gene Expression Signatures for Tumor Progression, Tumor Subtype, and Tumor Thickness in Laser-Microdissected Melanoma Tissues Clin. Cancer Res., February 1, 2007; 13(3): 806 - 815. [Abstract] [Full Text] [PDF]

				J. Choi, Y. K. Hwang, K. W. Sung, S. H. Lee, K. H. Yoo, H. L. Jung, H. H. Koo, H.-J. Kim, H. J. Kang, H. Y. Shin, et al. Expression of Livin, an antiapoptotic protein, is an independent favorable prognostic factor in childhood acute lymphoblastic leukemia Blood, January 15, 2007; 109(2): 471 - 477. [Abstract] [Full Text] [PDF]

				M. A. Shipp Molecular Signatures Define New Rational Treatment Targets in Large B-Cell Lymphomas Hematology, January 1, 2007; 2007(1): 265 - 269. [Abstract] [Full Text] [PDF]

				N. Rifai and R. E. Gerszten Biomarker Discovery and Validation Clin. Chem., September 1, 2006; 52(9): 1635 - 1637. [Full Text] [PDF]

				A. J. Holloway, D. S. Diyagama, K. Opeskin, J. Creaney, B. W.S. Robinson, R. A. Lake, and D. D.L. Bowtell A Molecular Diagnostic Test for Distinguishing Lung Adenocarcinoma from Malignant Mesothelioma Using Cells Collected from Pleural Effusions Clin. Cancer Res., September 1, 2006; 12(17): 5129 - 5135. [Abstract] [Full Text] [PDF]

				D. W. Lin, I. M. Coleman, S. Hawley, C. Y. Huang, R. Dumpit, D. Gifford, P. Kezele, H. Hung, B. S. Knudsen, A. R. Kristal, et al. Influence of Surgical Manipulation on Prostate Gene Expression: Implications for Molecular Correlates of Treatment Effects and Disease Prognosis J. Clin. Oncol., August 10, 2006; 24(23): 3763 - 3770. [Abstract] [Full Text] [PDF]

				M. V. Fournier, K. J. Martin, P. A. Kenny, K. Xhaja, I. Bosch, P. Yaswen, and M. J. Bissell Gene expression signature in organized and growth-arrested mammary acini predicts good outcome in breast cancer. Cancer Res., July 15, 2006; 66(14): 7095 - 7102. [Abstract] [Full Text] [PDF]

				M. West, G. S. Ginsburg, A. T. Huang, and J. R. Nevins Embracing the complexity of genomic data for personalized medicine. Genome Res., May 1, 2006; 16(5): 559 - 566. [Abstract] [Full Text] [PDF]

				C. R. Estrada, M. Salanga, D. R. Bielenberg, W. B. Harrell, D. Zurakowski, X. Zhu, M. R. Palmer, M. R. Freeman, and R. M. Adam Behavioral Profiling of Human Transitional Cell Carcinoma Ex vivo. Cancer Res., March 15, 2006; 66(6): 3078 - 3086. [Abstract] [Full Text] [PDF]

				K. Anderson, K. R. Hess, M. Kapoor, S. Tirrell, J. Courtemanche, B. Wang, Y. Wu, Y. Gong, G. N. Hortobagyi, W. F. Symmans, et al. Reproducibility of Gene Expression Signature-Based Predictions in Replicate Experiments Clin. Cancer Res., March 15, 2006; 12(6): 1721 - 1727. [Abstract] [Full Text] [PDF]

				I.-J. Kim, H. C. Kang, S.-G. Jang, K. Kim, S.-A Ahn, H.-J. Yoon, S. N. Yoon, and J.-G. Park Oligonucleotide microarray analysis of distinct gene expression patterns in colorectal cancer tissues harboring BRAF and K-ras mutations Carcinogenesis, March 1, 2006; 27(3): 392 - 404. [Abstract] [Full Text] [PDF]

				D. Chowdary, J. Lathrop, J. Skelton, K. Curtin, T. Briggs, Y. Zhang, J. Yu, Y. Wang, and A. Mazumder Prognostic Gene Expression Signatures Can Be Measured in Tissues Collected in RNAlater Preservative J. Mol. Diagn., February 1, 2006; 8(1): 31 - 39. [Abstract] [Full Text] [PDF]

				L. Gianni, M. Zambetti, K. Clark, J. Baker, M. Cronin, J. Wu, G. Mariani, J. Rodriguez, M. Carcangiu, D. Watson, et al. Gene Expression Profiles in Paraffin-Embedded Core Biopsy Tissue Predict Response to Chemotherapy in Women With Locally Advanced Breast Cancer J. Clin. Oncol., October 10, 2005; 23(29): 7265 - 7277. [Abstract] [Full Text] [PDF]

				T.-K. Man, M. Chintagumpala, J. Visvanathan, J. Shen, L. Perlaky, J. Hicks, M. Johnson, N. Davino, J. Murray, L. Helman, et al. Expression Profiles of Osteosarcoma That Can Predict Response to Chemotherapy Cancer Res., September 15, 2005; 65(18): 8142 - 8150. [Abstract] [Full Text] [PDF]

				L. Bullinger and P. J.M. Valk Gene Expression Profiling in Acute Myeloid Leukemia J. Clin. Oncol., September 10, 2005; 23(26): 6296 - 6305. [Abstract] [Full Text] [PDF]

				J. F. Torres-Roca, S. Eschrich, H. Zhao, G. Bloom, J. Sung, S. McCarthy, A. B. Cantor, A. Scuto, C. Li, S. Zhang, et al. Prediction of Radiation Sensitivity Using a Gene Expression Classifier Cancer Res., August 15, 2005; 65(16): 7169 - 7176. [Abstract] [Full Text] [PDF]

				J. Stec, J. Wang, K. Coombes, M. Ayers, S. Hoersch, D. L. Gold, J. S Ross, K. R. Hess, S. Tirrell, G. Linette, et al. Comparison of the Predictive Accuracy of DNA Array-Based Multigene Classifiers across cDNA Arrays and Affymetrix GeneChips J. Mol. Diagn., August 1, 2005; 7(3): 357 - 367. [Abstract] [Full Text] [PDF]

				R. J. Gilbertson ERBB2 in Pediatric Cancer: Innocent Until Proven Guilty Oncologist, August 1, 2005; 10(7): 508 - 517. [Abstract] [Full Text] [PDF]

				T. W. Vogel, Z. Zhuang, J. Li, H. Okamoto, M. Furuta, Y.-S. Lee, W. Zeng, E. H. Oldfield, A. O. Vortmeyer, and R. J. Weil Proteins and Protein Pattern Differences between Glioma Cell Lines and Glioblastoma Multiforme Clin. Cancer Res., May 15, 2005; 11(10): 3624 - 3632. [Abstract] [Full Text] [PDF]

				A. Berchuck, E. S. Iversen, J. M. Lancaster, J. Pittman, J. Luo, P. Lee, S. Murphy, H. K. Dressman, P. G. Febbo, M. West, et al. Patterns of Gene Expression That Characterize Long-term Survival in Advanced Stage Serous Ovarian Cancers Clin. Cancer Res., May 15, 2005; 11(10): 3686 - 3696. [Abstract] [Full Text] [PDF]

				B. A. Rupnow, M. Nicoll, R. P. Ryseck, M. I. Cockett, T. W. Wong, D. Jackson, K. Fitzgerald, T. Heuer, R. Blake, F. Lee, et al. Pathway-Oriented Oncology Target Discovery Am. Assoc. Cancer Res. Educ. Book, April 1, 2005; 2005(1): 41 - 44. [Full Text] [PDF]

				F. Bertucci, P. Finetti, J. Rougemont, E. Charafe-Jauffret, N. Cervera, C. Tarpin, C. Nguyen, L. Xerri, R. Houlgatte, J. Jacquemier, et al. Gene Expression Profiling Identifies Molecular Subtypes of Inflammatory Breast Cancer Cancer Res., March 15, 2005; 65(6): 2170 - 2178. [Abstract] [Full Text] [PDF]

				L. C. Hartmann, K. H. Lu, G. P. Linette, W. A. Cliby, K. R. Kalli, D. Gershenson, R. C. Bast, J. Stec, N. Iartchouk, D. I. Smith, et al. Gene Expression Profiles Predict Early Relapse in Ovarian Cancer after Platinum-Paclitaxel Chemotherapy Clin. Cancer Res., March 15, 2005; 11(6): 2149 - 2155. [Abstract] [Full Text] [PDF]

				T. Kreiner and K. T. Buck Moving toward whole-genome analysis: A technology perspective Am. J. Health Syst. Pharm., February 1, 2005; 62(3): 296 - 305. [Abstract] [Full Text] [PDF]

				Y. L. Yap, M. P. Wong, X. W. Zhang, D. Hernandez, R. Gras, D. K. Smith, and A. Danchin Conserved transcription factor binding sites of cancer markers derived from primary lung adenocarcinoma microarrays Nucleic Acids Res., January 14, 2005; 33(1): 409 - 421. [Abstract] [Full Text] [PDF]

				L.A. GARRAWAY, B.A. WEIR, X. ZHAO, H. WIDLUND, R. BEROUKHIM, A. BERGER, D. RIMM, M.A. RUBIN, D.E. FISHER, M.L. MEYERSON, et al. "Lineage Addiction" in Human Cancer: Lessons from Integrated Genomics Cold Spring Harb Symp Quant Biol, January 1, 2005; 70(0): 25 - 34. [Abstract] [PDF]

				M. Michael and M.M. Doherty Tumoral Drug Metabolism: Overview and Its Implications for Cancer Therapy J. Clin. Oncol., January 1, 2005; 23(1): 205 - 229. [Abstract] [Full Text] [PDF]

				L. Pusztai and K. R. Hess Clinical trial design for microarray predictive marker discovery and assessment Ann. Onc., December 1, 2004; 15(12): 1731 - 1737. [Abstract] [Full Text] [PDF]

				M. Bibikova, J. M. Yeakley, E. Chudin, J. Chen, E. Wickham, J. Wang-Rodriguez, and J.-B. Fan Gene Expression Profiles in Formalin-Fixed, Paraffin-Embedded Tissues Obtained with a Novel Assay for Microarray Analysis Clin. Chem., December 1, 2004; 50(12): 2384 - 2386. [Full Text] [PDF]

				S. Skates and O. Iliopoulos Molecular Markers for Early Detection of Renal Carcinoma: Investigative Approach Clin. Cancer Res., September 15, 2004; 10(18): 6296S - 6301S. [Abstract] [Full Text] [PDF]

				D. J. Samson, J. Seidenfeld, K. Ziegler, and N. Aronson Chemotherapy Sensitivity and Resistance Assays: A Systematic Review J. Clin. Oncol., September 1, 2004; 22(17): 3618 - 3630. [Abstract] [Full Text] [PDF]

				J. M. Cuezva, G. Chen, A. M. Alonso, A. Isidoro, D. E. Misek, S. M. Hanash, and D. G. Beer The bioenergetic signature of lung adenocarcinomas is a molecular marker of cancer diagnosis and prognosis Carcinogenesis, July 1, 2004; 25(7): 1157 - 1163. [Abstract] [Full Text] [PDF]

				M. H. Asyali, M. M. Shoukri, O. Demirkaya, and K. S. A. Khabar Assessment of reliability of microarray data and estimation of signal thresholds using mixture modeling Nucleic Acids Res., April 27, 2004; 32(8): 2323 - 2335. [Abstract] [Full Text] [PDF]

				W. D Stein, T. Litman, T. Fojo, and S. E Bates A Serial Analysis of Gene Expression (SAGE) Database Analysis of Chemosensitivity: Comparing Solid Tumors with Cell Lines and Comparing Solid Tumors from Different Tissue Origins Cancer Res., April 15, 2004; 64(8): 2805 - 2816. [Abstract] [Full Text] [PDF]

				A. Fernandez-Teijeiro, R. A. Betensky, L. M. Sturla, J. Y.H. Kim, P. Tamayo, and S. L. Pomeroy Combining Gene Expression Profiles and Clinical Parameters for Risk Stratification in Medulloblastomas J. Clin. Oncol., March 15, 2004; 22(6): 994 - 998. [Abstract] [Full Text] [PDF]

				Session 2: Molecular Diagnostics: Molecular Diagnostics: Chairman's Introduction JOHN F. LECHNER, Office of Technology for Diagnostics Systems, Bayer Diagnostics, Berkeley, California 94702 Toxicol Pathol, January 1, 2004; 32(1): 137 - 138. [PDF]

				The Future is Now: Oncology Pharmacogenetics and Pharmacogenomics Reach the Bedside: JEFFREY S. ROSS, Division of Molecular Medicine, Millennium Pharmaceuticals, Cambridge, Massachusetts 02139 and Department of Pathology, Albany Medical College, Albany, New York Toxicol Pathol, January 1, 2004; 32(1): 150 - 152. [PDF]

				G. Bloom, I. V. Yang, D. Boulware, K. Y. Kwong, D. Coppola, S. Eschrich, J. Quackenbush, and T. J. Yeatman Multi-Platform, Multi-Site, Microarray-Based Human Tumor Classification Am. J. Pathol., January 1, 2004; 164(1): 9 - 16. [Abstract] [Full Text] [PDF]

				F. E. Davies, A. M. Dring, C. Li, A. C. Rawstron, M. A. Shammas, S. M. O'Connor, J. A.L. Fenton, T. Hideshima, D. Chauhan, I. T. Tai, et al. Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis Blood, December 15, 2003; 102(13): 4504 - 4511. [Abstract] [Full Text] [PDF]

				S. Godard, G. Getz, M. Delorenzi, P. Farmer, H. Kobayashi, I. Desbaillets, M. Nozaki, A.-C. Diserens, M.-F. Hamou, P.-Y. Dietrich, et al. Classification of Human Astrocytic Gliomas on the Basis of Gene Expression: A Correlated Group of Genes with Angiogenic Activity Emerges As a Strong Predictor of Subtypes Cancer Res., October 15, 2003; 63(20): 6613 - 6625. [Abstract] [Full Text] [PDF]

				D. H. Johnson and C. L. Arteaga Gefitinib in Recurrent Non-Small-Cell Lung Cancer: An IDEAL Trial? J. Clin. Oncol., June 15, 2003; 21(12): 2227 - 2229. [Full Text] [PDF]

				Z.-Y. Wang, Q. Zhang, J. Wilson, M. Z. Ratajczak, and M. A. Wasik Detection of Protein Tyrosine-Kinase (PTK) Gene Expression Pattern in Normal and Malignant T Lymphocytes by Combined PTK-Specific Polymerase Chain Reaction and Parallel Denaturing Gradient Gel Electrophoresis J. Mol. Diagn., May 1, 2003; 5(2): 113 - 120. [Abstract] [Full Text] [PDF]

				E. C. Baechler, F. M. Batliwalla, G. Karypis, P. M. Gaffney, W. A. Ortmann, K. J. Espe, K. B. Shark, W. J. Grande, K. M. Hughes, V. Kapur, et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus PNAS, March 4, 2003; 100(5): 2610 - 2615. [Abstract] [Full Text] [PDF]

				R. M. Braziel, M. A. Shipp, A. L. Feldman, V. Espina, M. Winters, E. S. Jaffe, E. F. Petricoin III, and L. A. Liotta Molecular Diagnostics Hematology, January 1, 2003; 2003(1): 279 - 293. [Abstract] [Full Text] [PDF]

				Appendix A: Color Figures Hematology, January 1, 2003; 2003(1): 597 - 618. [Full Text]

				T. A. Plunkett and P. A. Ellis CEACAM1: A Marker With a Difference or More of the Same? J. Clin. Oncol., November 1, 2002; 20(21): 4273 - 4275. [Full Text] [PDF]

				R. Romero, H. Kuivaniemi, and G. Tromp Functional Genomics and Proteomics in Term and Preterm Parturition J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2431 - 2434. [Full Text] [PDF]

				F. J. Giles, A. Keating, A. H. Goldstone, I. Avivi, C. L. Willman, and H. M. Kantarjian Acute Myeloid Leukemia Hematology, January 1, 2002; 2002(1): 73 - 110. [Abstract] [Full Text]